SuperworthSeres Therapeutics shares outstanding MCRB
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 9.7M
- On a year earlier
- +11.5%
- more shares
Seres Therapeutics had 9.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 11.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 9.2M | +8% |
| FY2024 | 8.6M | +32% |
| FY2023 | 6.5M | +4% |
| FY2022 | 6.2M | +36% |
| FY2021 | 4.6M | +1% |
| FY2020 | 4.6M | +30% |
| FY2019 | 3.5M | +71% |
| FY2018 | 2M | +1% |
| FY2017 | 2M | +0% |
| FY2016 | 2M | +3% |
| FY2015 | 2M | +475% |
| FY2014 | 339.8K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 9.7M | +11% | |
| Q1 FY26 | 9.6M | +10% | |
| Q4 FY25 | 9.2M | +8% | |
| Q3 FY25 | 8.8M | +15% | |
| Q2 FY25 | 8.7M | +15% | |
| Q1 FY25 | 8.7M | +19% | |
| Q4 FY24 | 8.6M | +32% | |
| Q3 FY24 | 7.6M | +19% | |
| Q2 FY24 | 7.6M | +17% | |
| Q1 FY24 | 7.3M | +16% | |
| Q4 FY23 | 6.5M | +4% | |
| Q3 FY23 | 6.4M | +5% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Seres Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.